<DOC>
	<DOCNO>NCT00285012</DOCNO>
	<brief_summary>This study conduct subject mild-to-moderate COPD cigarette smoker intent demonstrate difference smoke cessation varenicline placebo .</brief_summary>
	<brief_title>Smoking Cessation Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease ( COPD ) .</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Subjects current cigarette smoker smoke average least 10 cigarette per day past year month prior screen visit . mild moderate COPD confirm spirometry Subjects must clinical diagnosis COPD . Subjects make serious attempt quit smoking past 3 month . Subjects previously randomize study include varenicline .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>smoke cessation</keyword>
	<keyword>smoke cessation COPD</keyword>
</DOC>